Stockholm Stock Exchange | Mid Cap
Camurus
+25.61%
Latest
+13.72%
3 months
DNBNordea MarketsCarnegiePareto SecuritiesJefferiesHandelsbankenDNB Markets

Price Targets For Camurus

AnalystPrice TargetDateUpside
DNB310 SEKSep 9
+25.61%
Nordea Markets270 SEKSep 7
Carnegie262 SEKJul 18
Pareto Securities290 SEKJul 1
Jefferies205 SEKApr 4
Handelsbanken235 SEKDec -21
DNB Markets275 SEKNov -21

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia